Group structure
12 companies in 7 countries
Loading your page…
Loading your page…
12 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 170
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARDIOGENGeneratore di radionuclidi | Rubidium (82 rb) chloride | Italy | Authorised | |
| CARDIOGEN-8282 n/a · Injectable | Rubidium rb-82 n/a | United States | Marketed | 1989 |
| Cardiogen-82 3,3-5,6 GBq radionuclide generatorRadionuclide generator | Rubidium (82 rb) chloride | Netherlands | Authorised | 2022 |
| CARDIOGRAFIN85% · Injectable | Diatrizoate | United States | Not marketed | 1958 |
| CARDIOTEC99m teboroxime kit n/a · Injectable | Technetium tc-99m teboroxime kit n/a | United States | Not marketed | 1990 |
| CHLORMERODRIN HG 197197 0.6-1.4mCi/ML · Injectable | Chlormerodrin hg-197 | United States | Not marketed | 1974 |
| CHOLETEC45 mg / vial · Powder For Solution | Technetium (99m tc) mebrofenin | Canada | Marketed | 2022 |
| CHOLETEC99m mebrofenin kit n/a · Injectable | Technetium tc-99m mebrofenin kit n/a | United States | Marketed | 1987 |
| CHOLOGRAFIN MEGLUMINE10.3% | 52% · Injectable | Adipiodone | United States | Not marketed | 1954 |
| CHOLOGRAFIN SODIUM20% · Injectable | Adipiodone | United States | Not marketed | 1954 |
| CHOLOVUE40.3% | 9.9% · Injectable | Iodoxamate | United States | Not marketed | 1981 |
| CHROMITOPE SODIUM51 200uCi/ML | 51 2mCi/VIAL · Injectable | Chromate cr-51 | United States | Not marketed | 1971 |
| CYSTOGRAFIN30% · Solution | Diatrizoate | United States | Marketed | 1955 |
| CYSTOGRAFIN DILUTE18% · Solution | Diatrizoate | United States | Marketed | 1955 |
| DIATRIZOATE MEGLUMINE76% · Injectable | Diatrizoate | United States | Not marketed | 1955 |
| E-Z-CAT 49 mg/ml suspensie voor oraal gebruikSuspensie voor oraal gebruik | Barium | Netherlands | Authorised | 1994 |
| E-Z-CAT DRY40% · For suspension | Barium | United States | Not marketed | 2016 |
| E-Z-DISK700mg · Tablet | Barium | United States | Marketed | 2025 |
| E-Z-HD98% · For suspension | Barium | United States | Marketed | 2016 |
| E-Z-HD 984,5 mg/g poeder voor orale suspensiePoeder voor orale suspensie | Barium | Netherlands | Authorised | 1990 |
| E-Z-PAQUE96% · For suspension | Barium | United States | Marketed | 2016 |
| ENTERO VU 24%24% · Suspension | Barium | United States | Marketed | 2016 |
| GASTROGRAFIN66 % + 10 % · Solution | Diatrizoate | Canada | Marketed | 1978 |
| GASTROGRAFIN66%; 10% · Solution | Diatrizoate | United States | Marketed | 1958 |
| GASTROMIROSoluzione gastroenterica | Iopamidol | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 68 | 68 | 0 | CompaniesAll medicines |
| Canada | 24 | 12 | 12 | CompaniesAll medicines |
| Spain | 14 | 13 | 1 | CompaniesAll medicines |
| Netherlands | 14 | 14 | 0 | CompaniesAll medicines |
| Romania | 11 | 0 | 11 | CompaniesAll medicines |
| Saudi Arabia | 11 | 11 | 0 | CompaniesAll medicines |
| Italy | 10 | 10 | 0 | CompaniesAll medicines |
| Brazil | 8 | 5 | 3 | CompaniesAll medicines |
| Croatia | 8 | 8 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci-con-dettaglio-autorizzazioni/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:44.771040+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.